Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 504.98M P/E - EPS this Y 45.30% Ern Qtrly Grth -
Income -198.64M Forward P/E -2.34 EPS next Y 47.50% 50D Avg Chg 11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 1.22 EPS next 5Y - 52W High Chg -94.00%
Recommedations 2.00 Quick Ratio 4.01 Shares Outstanding 119.22M 52W Low Chg 93.00%
Insider Own 18.21% ROA -42.42% Shares Float 49.62M Beta 0.63
Inst Own 63.93% ROE -74.48% Shares Shorted/Prior 4.25M/1.64M Price 4.64
Gross Margin - Profit Margin - Avg. Volume 660,960 Target Price 9.38
Oper. Margin - Earnings Date - Volume 534,999 Change 0.87%
About Adagio Therapeutics, Inc.

Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. It developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering. The company's pipeline includes PEMGRADA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate which is in preclinical studies for the prevention or treatment for COVID-19; and adintrvimab, that is in phase 3 clinical trials for the prevention or treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. Invivyd, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.

Adagio Therapeutics, Inc. News
04/15/24 Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
04/12/24 Invivyd Announces CEO Transition
04/07/24 We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate
04/04/24 Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
03/28/24 Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
03/22/24 Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
03/22/24 Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
02/05/24 Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/29/24 3 Groundbreaking Biotech Stocks to Invest in Now
01/19/24 When Will Invivyd, Inc. (NASDAQ:IVVD) Become Profitable?
01/12/24 All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy
01/03/24 Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents
12/23/23 Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
12/19/23 Invivyd (IVVD) Surges on Positive Data From COVID-19 Study
12/18/23 Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
11/13/23 Invivyd, Inc. (NASDAQ:IVVD) Q3 2023 Earnings Call Transcript
11/10/23 Q3 2023 Invivyd Inc Earnings Call
11/09/23 Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
11/02/23 Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights
10/31/23 Invivyd to Participate in Upcoming Investor Conferences
IVVD Chatroom

User Image JacksonLeon Posted - 1 day ago

$IVVD if IVVD not able to break SMA200, we will see $2.00 then $1.70

User Image dashtone Posted - 1 day ago

$IVVD isxths F*ed up or what?

User Image JacksonLeon Posted - 2 days ago

$IVVD Resistance at SMA200, if it break out we will see higher high, higher low, beautiful uptrend.

User Image alexx013 Posted - 2 days ago

$IVVD bottom is in, north from here

User Image GakiYoui_Atsu Posted - 4 days ago

$WIMI We need more! $FFIE $IVVD

User Image JacksonLeon Posted - 1 week ago

$IVVD Drop below SMA200, next support is to fill the gap between $1.75 - $2.0. This is exactly my initial prediction that IVVD will try to fill the gap at $1.75. If there is no sign of reversal, that's pretty high chance it will fill the gap.

User Image dashtone Posted - 1 week ago

$IVVD with all the approvals and stamps to move forward. This should’ve been 6070 $80.

User Image dashtone Posted - 1 week ago

$IVVD what a shitshow

User Image doubleyou2 Posted - 1 week ago

$VXRT $IVVD At the moment both ill in the same bed?

User Image daarkmatter Posted - 1 week ago

$IVVD I'm concerned by the lack of enthusiasm from the tutes in particular at this stage. It's almost like they want to see the actual sales before trusting this stock again. Hope all goes well for the team, and it raises the price eventually. Wonder how low it can go to find support. Back to $1.50s to $2 before we get another news ?

User Image luiselen Posted - 1 week ago

Target price $MU 125 $IVVD 5 $WIMI 2 $AMC 7

User Image JacksonLeon Posted - 1 week ago

$IVVD and $VXRT If there are major market pullback in the next few days to weeks, we could see IVVD and VXRT retest at SMA200, it’s not a good sign if drop below SMA200.

User Image TWITLIEDETECTOR Posted - 1 week ago

$IVVD From my perspective, this is now a low stress waiting game.....

User Image Skynet7 Posted - 1 week ago

$IVVD

User Image Nik_CA Posted - 1 week ago

$IVVD has already sold and shipped pemgarda. With Q and M codes already received, the reimbursement (and revenue) should follow soon.

User Image G101SPM Posted - 1 week ago

$IVVD $2.80 ask... BUY/REVISIT carries SPM 84.26 tag to warrant EXIT at $4.50. UPDATE: (1) Announces that the U.S. Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System Q code (Q0224) covering product reimbursement for PEMGARDA (2.95) Product-specific Q Code (Q0224) facilitates product reimbursement for PEMGARDA; corresponding M Code (M0224) defines reimbursement for product administration. Reimbursement through Medicare/Medicaid represents approximately 50% of covered lives in target population; (2) appointed Jeremy Gowler as Interim CEO effective immediately, while the Board institutes a search for a permanent CEO. Mr. Gowler succeeds Dave Herin.

User Image Stock_Titan Posted - 1 week ago

$IVVD Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™ https://www.stocktitan.net/news/IVVD/invivyd-receives-healthcare-common-procedure-coding-system-hcpcs-c4oxe4ir9s4b.html

User Image Nik_CA Posted - 1 week ago

$IVVD @TWITLIEDETECTOR @JacksonLeon @Hamie3378 Based on the open positions, where is this company heading?

User Image Nik_CA Posted - 1 week ago

$IVVD Here's LI profile of the interim CEO, Jeremy Gowler.

User Image Nik_CA Posted - 1 week ago

$IVVD @TWITLIEDETECTOR @Hamie3378 @JacksonLeon CEO transition seems to me that maybe they are readying the company for acquisition. Any thoughts?

User Image Stock_Titan Posted - 1 week ago

$IVVD Invivyd Announces CEO Transition https://www.stocktitan.net/news/IVVD/invivyd-announces-ceo-nskupl3a4caa.html

User Image luiselen Posted - 2 weeks ago

Target price next week $AMC 5 $WIMI 2 $IVVD 5

User Image ZACHSPIZZA Posted - 2 weeks ago

$IVVD go baby

User Image luiselen Posted - 2 weeks ago

Target price for $MU 125 $WIMI 2 $AMC 5 $IVVD 4

User Image DavidMichery12345 Posted - 2 weeks ago

$IVVD looking good. Just grabbed 20k more shares

User Image JacksonLeon Posted - 2 weeks ago

$IVVD @TWITLIEDETECTOR @Nik_CA IVVD respecting the trendline, it retraces back to the lower trendline, let's see if it can bounce from here. Current price $2.94, very near to my buy price of $2.88

User Image coolio999 Posted - 2 weeks ago

$IVVD started a small position today

User Image alexx013 Posted - 2 weeks ago

$IVVD added @ 2.94

User Image doubleyou2 Posted - 2 weeks ago

$IVVD Currect published target prices : we have an average of $11.33 of those latest 3. I can live with that . * $9.00 Guggenheim (April 5th 2024) * $15.00 HC Wainwright (March 25th 2024) * $10.00 Morgan Stanley (March 26th 2024)

User Image Nik_CA Posted - 2 weeks ago

$IVVD Recently, PRs have been released on Thursdays and Fridays. Will this trend continue or were they just one offs?

Analyst Ratings
Guggenheim Buy Apr 5, 24
Morgan Stanley Overweight Mar 26, 24
HC Wainwright & Co. Buy Mar 25, 24
HC Wainwright & Co. Buy Jan 18, 24
Morgan Stanley Equal-Weight Dec 19, 23
HC Wainwright & Co. Buy Aug 14, 23
HC Wainwright & Co. Buy Jul 18, 23
HC Wainwright & Co. Buy Jun 23, 23
HC Wainwright & Co. Buy May 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Elia Marc Director Director Aug 17 Buy 4.32 2,850,000 12,312,000 9,248,250 08/19/22
Royan Ajay Director Director Aug 12 Buy 17 1,997,000 33,949,000 11,241,580 08/12/21